With urokinase-type plasminogen activator receptor and epidermal growth factor receptor, TF can be also considered a prognostic biomarker in OSCC and could potentially be attractive targets for molecular imaging and therapy in OSCC due to its high positive expression rates and tumour-specific expression patterns [13,14]. This evidence concerns the gene TF and neoplasm.